Alcansado, Jenny .
HRN: 13-73-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/13/2024
MUPIROCIN 2%, 15G (TUBE)
10/13/2024
10/14/2024
TOPICAL
15mg
OD
S/p CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes